Accretion Pharmaceuticals Ltd

Accretion Pharmaceuticals Ltd IPO

Accretion Pharmaceuticals Ltd IPO Price Range is ₹96 - 101, with a minimum investment of ₹1,21,200 for 1200 shares.

₹1,21,200

/ 1200 shares

Minimum Investment

View Accretion Pharmaceuticals Ltd IPO details including price range, minimum investment, lot size, financials, and IPO timeline. Get subscription updates, peer comparison, and key insights to help you make an informed decision.

IPO Status

Closed

Price Band

₹96 - 101

Open Date

2025-05-14

Close Date

2025-05-16

IPO Size

₹29.75 Cr

Lot Size

1200 shares

Min Investment

₹1,21,200

Listing Exchange

NSE

Accretion Pharmaceuticals Ltd IPO Application Timeline

passed
Open Date14 May 2025
passed
Close Date16 May 2025
passed
Allotment Date19 May 2025
passed
Listing Date21 May 2025

IPO Subscription Status

IPO subscribed over

🚀 7.315x

This IPO has been subscribed by 10.546x in the retail category and 4.874x in the QIB category.

Subscription Rate

Total Subscription7.315x
Retail Individual Investors10.546x
Qualified Institutional Buyers4.874x
Non Institutional Investors4.409x
NameAccretion Pharmaceuticals Ltdx

Strengths and Risks

Strengths

Strengths

  • Experienced Promoters and Management Team.

  • Consistently supplying quality products to our valued customers in time.

  • Continually improving the quality standards by implementing process control and prevention techniques.

  • Long-standing relationship with clients and suppliers.

  • Quality standards.

  • Legacy Business Process & Management.

  • Strong and experienced R&D team.


Risks

Risks

  • A significant portion of its revenue is derived from exports, and any decline in exportprofitability may adversely impact its overall financial performance.

  • The Company operates in pharmaceutical sector, which is extensively regulated, any failures onthe company part to comply with the existing and future statutory and/or regulatory requirements in the pharmaceutical sector could adversely affect its business, results of operations and financialcondition.

  • Its manufacturing units are subject to periodic inspections and audits by regulatory authoritiesand clients. Its may be subject to regulatory action which may damage the company reputation leading to an adverse effect on its business, results of operations, financial condition and cash flows.

  • The company has a very limited operating history as a Company, which may make it difficult for investors to evaluate its historical performance or future prospects.

  • The company has only one Manufacturing Facility, continued operations of its manufacturing facility is critical to the company business and any disruption in the operation of its manufacturing facility may have a material adverse effect on the company business, results of operations and financial condition.

  • The company generate a significant percentage of its revenue from few clients. The loss of any one or more of the company major clients would have a material adverse effect on its business operations and profitability.

  • Its inability to accurately forecast demand for the company products or manage its inventory or working capital requirements may have an adverse effect on the company business, results of operations and financial condition.

  • There was a Criminal litigation against its promoters cum directors and the company is not sure the same shall not be refiled by the concerned authority. In the event it is refiled, the interest of the promoters may divert from the business of the Company, which may adversely affect the business of the Company.

  • Its business operations are working capital intensive, and any inability to meet the company working capital requirements may adversely impact its financial condition and growth prospects.

  • The company has certain outstanding litigation against it, an adverse outcome of which may adversely affect its business, reputation and results of operations.

How to Apply for Accretion Pharmaceuticals Ltd IPO on INDmoney

1

Download the INDmoney app and complete your KYC to open an account.

2

Go to the INDstocks section and tap on IPO, or search for ‘IPO’.

3

Select Accretion Pharmaceuticals Ltd IPO from the list of live IPOs.

4

View key details like price band, lot size, and dates, then tap ‘Apply Now’.

5

Choose the number of lots and place your order via UPI.

6

Your funds will be blocked until the share allotment is finalized.

About Accretion Pharmaceuticals Ltd

Presently our Company is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), And Oral Powder (Sachet, Dry Syrup) etc.

Frequently Asked Questions of Accretion Pharmaceuticals Ltd IPO

What is the size of the Accretion Pharmaceuticals Ltd IPO?

The size of the Accretion Pharmaceuticals Ltd IPO is ₹29.75 Cr.

What is the allotment date of the Accretion Pharmaceuticals Ltd IPO?

Accretion Pharmaceuticals Ltd IPO allotment date is May 19, 2025 (tentative).

What are the open and close dates of the Accretion Pharmaceuticals Ltd IPO?

The Accretion Pharmaceuticals Ltd IPO will open on May 14, 2025 and close on May 16, 2025

What is the lot size of Accretion Pharmaceuticals Ltd IPO?

The lot size for the Accretion Pharmaceuticals Ltd IPO is 1200.

When will my Accretion Pharmaceuticals Ltd IPO order be placed?

Your Accretion Pharmaceuticals Ltd IPO order will be placed on May 14, 2025

Can we invest in Accretion Pharmaceuticals Ltd IPO?

Yes, once Accretion Pharmaceuticals Ltd IPO opens, you can invest in the shares of the company.

What would be the listing gains on the Accretion Pharmaceuticals Ltd IPO?

The potential listing gains on the Accretion Pharmaceuticals Ltd IPO will depend on various market factors and cannot be predicted with certainty.

What is 'pre-apply' for Accretion Pharmaceuticals Ltd IPO?

'Pre-apply' for Accretion Pharmaceuticals Ltd IPO indicates your interest in the IPO before it opens for subscription. This ensures quick application when the IPO goes live.